Creatine supplementation as a possible new therapeutic approach for fatty liver disease: early findings

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Amino Acids

• Publication date

  2016-01-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00726-016-2183-6PMID 26832170
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nonalcoholic fatty liver disease: new treatments

  2015cited by this paper
• Betaine supplementation prevents fatty liver induced by a high-fat diet: effects on one-carbon metabolism

  2015cited by this paper
• Nonalcoholic fatty liver disease: Update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine

  2015cited by this paper
• The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease.

  2015cited by this paper
• A creatine-driven substrate cycle enhances energy expenditure and thermogenesis in beige fat.

  2015influential reference
• Pharmacotherapy for Nonalcoholic Fatty Liver Disease

  2015cited by this paper
• Creatine supplementation prevents fatty liver in rats fed choline-deficient diet: a burden of one-carbon and fatty acid metabolism.

  2015cited by this paper
• PPARα-Deficient ob/ob Obese Mice Become More Obese and Manifest Severe Hepatic Steatosis Due to Decreased Fatty Acid Oxidation.

  2015cited by this paper
• PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.

  2015cited by this paper
• Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: Results from the WELCOME* study

  2014cited by this paper
• Choline supplementation protects against liver damage by normalizing cholesterol metabolism in Pemt/Ldlr knockout mice fed a high-fat diet.

  2014cited by this paper
• Clinical approaches to non-alcoholic fatty liver disease.

  2014influential reference
• Creatine reduces hepatic TG accumulation in hepatocytes by stimulating fatty acid oxidation.

  2014cited by this paper
• Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: Cause or consequence?

  2013cited by this paper
• Physiological roles of phosphatidylethanolamine N-methyltransferase.

  2013cited by this paper
• Differential regulation of AMPK activation in leptin‐and creatine‐deficient mice

  2013cited by this paper
• L-arginine:glycine amidinotransferase deficiency protects from metabolic syndrome.

  2013cited by this paper
• PPARγ signaling and metabolism: the good, the bad and the future

  2013cited by this paper
• Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease

  2013influential reference
• Dietary fructose in nonalcoholic fatty liver disease

  2013influential reference
• Roles of PPARs in NAFLD: potential therapeutic targets.

  2012cited by this paper
• Creatine-induced glucose uptake in type 2 diabetes: a role for AMPK-α?

  2012cited by this paper
• PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver.

  2011cited by this paper
• The metabolic burden of creatine synthesis

  2011cited by this paper
• PPAR a Expression Protects Male Mice from High Fat–Induced Nonalcoholic Fatty Liver 1–3

  2011cited by this paper
• Creatine supplementation prevents the accumulation of fat in the livers of rats fed a high-fat diet.

  2011cited by this paper
• Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.

  2011cited by this paper
• The creatine kinase system and pleiotropic effects of creatine

  2011cited by this paper
• Therapeutic effects of exercise training in patients with pediatric rheumatic diseases.

  2011cited by this paper
• Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease

  2011influential reference
• Specific Contribution of Methionine and Choline in Nutritional Nonalcoholic Steatohepatitis

  2010cited by this paper
• Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis

  2010influential reference
• Fitness versus fatness: Moving beyond weight loss in nonalcoholic fatty liver disease

  2010cited by this paper
• The association of genetic variability in patatin‐like phospholipase domain‐containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease

  2010influential reference
• A meta‐analysis of randomized trials for the treatment of nonalcoholic fatty liver disease

  2010cited by this paper
• Impaired de Novo Choline Synthesis Explains Why Phosphatidylethanolamine N-Methyltransferase-deficient Mice Are Protected from Diet-induced Obesity*

  2010cited by this paper
• AMP‐activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives

  2009cited by this paper
• Impaired sulfur-amino acid metabolism and oxidative stress in nonalcoholic fatty liver are alleviated by betaine supplementation in rats.

  2009cited by this paper
• Creatine synthesis: hepatic metabolism of guanidinoacetate and creatine in the rat in vitro and in vivo.

  2009cited by this paper
• Exploring the therapeutic role of creatine supplementation

  2009cited by this paper
• Impact of increased PPARgamma activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment.

  2008cited by this paper
• Hepatic CTP:Phosphocholine Cytidylyltransferase-α Is a Critical Predictor of Plasma High Density Lipoprotein and Very Low Density Lipoprotein*

  2008cited by this paper
• Impact of increased PPARγ activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment

  2008cited by this paper
• Effects of creatine supplementation on homocysteine levels and lipid peroxidation in rats

  2008cited by this paper
• Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice.

  2008cited by this paper
• Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway.

  2007cited by this paper
• Creatine synthesis: production of guanidinoacetate by the rat and human kidney in vivo.

  2007cited by this paper
• Creatine: endogenous metabolite, dietary, and therapeutic supplement.

  2007cited by this paper
• Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus.

  2007cited by this paper
• Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects.

  2006cited by this paper
• The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis.

  2006influential reference
• Is it time to reevaluate methyl balance in humans?

  2006cited by this paper
• Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

  2005cited by this paper
• Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD)

  2005influential reference
• Creatine supplementation increases glucose oxidation and AMPK phosphorylation and reduces lactate production in L6 rat skeletal muscle cells

  2004cited by this paper
• Liver Peroxisome Proliferator-activated Receptor γ Contributes to Hepatic Steatosis, Triglyceride Clearance, and Regulation of Body Fat Mass*

  2003cited by this paper
• Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis

  2003cited by this paper
• Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.

  2003cited by this paper
• Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.

  2002cited by this paper
• Folate, vitamin B12 and vitamin B6 and one carbon metabolism.

  2002cited by this paper
• Methylation demand and homocysteine metabolism: effects of dietary provision of creatine and guanidinoacetate.

  2001cited by this paper
• Role of AMP-activated protein kinase in mechanism of metformin action.

  2001cited by this paper
• Creatine and creatinine metabolism.

  2000influential reference
• Dual regulation of the AMP‐activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle

  1998cited by this paper
• Steatohepatitis: a tale of two "hits"?

  1998cited by this paper
• High-performance capillary electrophoresis-pure creatine monohydrate reduces blood lipids in men and women.

  1996cited by this paper
• Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation.

  1992cited by this paper
• The creatine-creatine phosphate energy shuttle.

  1985cited by this paper
• The rapid induction of liver cell death in rats fed a choline-deficient methionine-low diet.

  1983cited by this paper
• Origins and roles of endogenous retroviruses.

  1980cited by this paper

• Efficacy of Supplementary Guanidinoacetic Acid at Different Dietary Crude Protein Levels on the Productive Performance, Egg Quality, Intestinal Morphology, Antioxidative Status, and Serum Metabolites of Aged Laying Hens Exposed to High Ambient Temperatures

  2026cites this paper
• Liver Metabolomic Profiling Reveals Distinct Signatures Between Steatosis and Metabolic Dysfunction‐Associated Steatohepatitis

  2026cites this paper
• Creatine supplementation attenuates high-starch-induced hepatic metabolic dysregulation and intestinal barrier dysfunction in largemouth bass (Micropterus salmoides)

  2026cites this paper
• The role of lactate in the body of martial artists during physical activity: a new look at the problem

  2025cites this paper
• Creatine monohydrate supplementation for older adults and clinical populations

  2025cites this paper
• Metabolic consequences of altered kidney glucose reabsorption under normoglycemic conditions

  2025cites this paper
• Circulatory Metabolite Ratios as Indicators of Lifestyle Risk Factors Based on a Greek NAFLD Case–Control Study

  2024cites this paper
• Mitochondrial targets in hyperammonemia: Addressing urea cycle function to improve drug therapies.

  2024cites this paper
• Creatine Supplementation Potentiates Exercise Protective Effects against Doxorubicin-Induced Hepatotoxicity in Mice

  2023cites this paper
• Serum metabolomic profiling unveils distinct sex-related metabolic patterns in NAFLD

  2023cites this paper
• Creatine in Sustainable Fish Aquaculture

  2023cites this paper
• Creatine Supplementation to Improve Sarcopenia in Chronic Liver Disease: Facts and Perspectives

  2023cites this paper
• Creatine supplementation protects against diet-induced non-alcoholic fatty liver but exacerbates alcoholic fatty liver.

  2022cites this paper
• Transcriptomics combined with metabolomics analysis of the mechanism of agmatine in the treatment of septic liver injury

  2022cites this paper
• Dietary Creatine Reduces Lipid Accumulation by Improving Lipid Catabolism in the Herbivorous Grass Carp, Ctenopharyngodon idella

  2022cites this paper
• Dietary intake of creatine and risk of medical conditions in U.S. older men and women: Data from the 2017–2018 National Health and Nutrition Examination Survey

  2021cites this paper
• Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show?

  2021cites this paper
• Liver enhancer signature and regulatory network of non-alcoholic steatohepatitis resistance in humans with obesity

  2021cites this paper
• One-Carbon Metabolism in Fatty Liver Disease and Fibrosis: One-Carbon to Rule Them All.

  2020cites this paper
• Effects of Guanidinoacetic acid supplements on laying performance, egg quality, liver nitric oxide and energy metabolism in laying hens at the late stage of production

  2020cites this paper
• Creatine supplementation does not promote tumor growth or enhance tumor aggressiveness in Walker-256 tumor-bearing rats.

  2020cites this paper
• Nonalcoholic fatty liver disease and sarcopenia: pathophysiological connections and therapeutic implications

  2020cites this paper
• Chenopodium Quinoa and Salvia Hispanica Provide Immunonutritional Agonists to Ameliorate Hepatocarcinoma Severity under a High-Fat Diet

  2020cites this paper
• Statistical Analyses for Gender Dependent Risk of Non-Alcoholic Fatty Liver in Non-Diabetic Patients

  2019cites this paper
• Predicting metabolite-disease associations based on KATZ model

  2019cites this paper
• Creatine supplementation exacerbates ethanol-induced hepatic damage in mice.

  2019cites this paper
• Intradialytic creatine supplementation: A scientific rationale for improving the health and quality of life of dialysis patients.

  2017cites this paper
• Innate Immunity As Mediator of Cell Death and Inflammation in Alcoholic Liver Disease

  2017cites this paper
• Dietary creatine supplementation lowers hepatic triacylglycerol by increasing lipoprotein secretion in rats fed high-fat diet.

  2017cites this paper
• Endoplasmic Reticulum Stress-induced Hepatocellular Death Pathways Mediate Liver Injury and Fibrosis via Stimulator of Interferon Genes*

  2016cites this paper
• Creatine: a miserable life without it

  2016cites this paper